NO20003853L - Compounds for therapy and diagnosis of lung cancer and methods for their use - Google Patents

Compounds for therapy and diagnosis of lung cancer and methods for their use

Info

Publication number
NO20003853L
NO20003853L NO20003853A NO20003853A NO20003853L NO 20003853 L NO20003853 L NO 20003853L NO 20003853 A NO20003853 A NO 20003853A NO 20003853 A NO20003853 A NO 20003853A NO 20003853 L NO20003853 L NO 20003853L
Authority
NO
Norway
Prior art keywords
diagnosis
therapy
compounds
methods
lung cancer
Prior art date
Application number
NO20003853A
Other languages
Norwegian (no)
Other versions
NO20003853D0 (en
Inventor
Steven G Reed
Michael J Lodes
Tony N Frudakis
Raodoh Mohamath
Original Assignee
Corixa Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Corixa Corp filed Critical Corixa Corp
Publication of NO20003853D0 publication Critical patent/NO20003853D0/en
Publication of NO20003853L publication Critical patent/NO20003853L/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/117—Nucleic acids having immunomodulatory properties, e.g. containing CpG-motifs
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/158—Expression markers

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • General Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Biomedical Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Analytical Chemistry (AREA)
  • Microbiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Physics & Mathematics (AREA)
  • Veterinary Medicine (AREA)
  • Immunology (AREA)
  • Pathology (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Pulmonology (AREA)
  • Plant Pathology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
NO20003853A 1998-01-28 2000-07-27 Compounds for therapy and diagnosis of lung cancer and methods for their use NO20003853L (en)

Applications Claiming Priority (8)

Application Number Priority Date Filing Date Title
US1502298A 1998-01-28 1998-01-28
US1502998A 1998-01-28 1998-01-28
US4083198A 1998-03-18 1998-03-18
US4082898A 1998-03-18 1998-03-18
US12219298A 1998-07-23 1998-07-23
US12219198A 1998-07-23 1998-07-23
US21924598A 1998-12-22 1998-12-22
PCT/US1999/001642 WO1999038973A2 (en) 1998-01-28 1999-01-26 Compounds for therapy and diagnosis of lung cancer and methods for their use

Publications (2)

Publication Number Publication Date
NO20003853D0 NO20003853D0 (en) 2000-07-27
NO20003853L true NO20003853L (en) 2000-09-27

Family

ID=27567530

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20003853A NO20003853L (en) 1998-01-28 2000-07-27 Compounds for therapy and diagnosis of lung cancer and methods for their use

Country Status (13)

Country Link
EP (1) EP1051489A2 (en)
JP (1) JP2002516659A (en)
KR (1) KR20010034436A (en)
CN (1) CN1292029A (en)
AR (1) AR014514A1 (en)
AU (1) AU2344399A (en)
BR (1) BR9907259A (en)
CA (1) CA2319117A1 (en)
ID (1) ID27813A (en)
IL (1) IL137417A0 (en)
NO (1) NO20003853L (en)
WO (1) WO1999038973A2 (en)
ZA (1) ZA99693B (en)

Families Citing this family (67)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6312695B1 (en) 1998-03-18 2001-11-06 Corixa Corporation Compounds and methods for therapy of lung cancer
US6821518B1 (en) 1998-03-18 2004-11-23 Corixa Corporation Compounds and methods for therapy and diagnosis of lung cancer
US6660838B1 (en) 1998-03-18 2003-12-09 Corixa Corporation Compounds and methods for therapy and diagnosis of lung cancer
US6531315B1 (en) 1998-03-18 2003-03-11 Corixa Corporation Compositions and methods for the therapy and diagnosis of lung cancer
US6518256B1 (en) 1998-03-18 2003-02-11 Corixa Corporation Compounds and methods for therapy and diagnosis of lung cancer
US7049063B2 (en) 1998-03-18 2006-05-23 Corixa Corporation Methods for diagnosis of lung cancer
US6737514B1 (en) 1998-12-22 2004-05-18 Corixa Corporation Compositions and methods for the therapy and diagnosis of lung cancer
US6482597B1 (en) 1999-12-17 2002-11-19 Corixa Corporation Compounds and methods for therapy and diagnosis of lung cancer
US7258860B2 (en) 1998-03-18 2007-08-21 Corixa Corporation Compositions and methods for the therapy and diagnosis of lung cancer
US6960570B2 (en) 1998-03-18 2005-11-01 Corixa Corporation Compositions and methods for the therapy and diagnosis of lung cancer
US7579160B2 (en) 1998-03-18 2009-08-25 Corixa Corporation Methods for the detection of cervical cancer
US6696247B2 (en) 1998-03-18 2004-02-24 Corixa Corporation Compounds and methods for therapy and diagnosis of lung cancer
US6706262B1 (en) 1998-03-18 2004-03-16 Corixa Corporation Compounds and methods for therapy and diagnosis of lung cancer
US6426072B1 (en) 2000-08-02 2002-07-30 Corixa Corporation Compositions and methods for the therapy and diagnosis of lung cancer
EP0987552A3 (en) * 1998-08-31 2000-06-07 Pfizer Products Inc. Diarylsulfonylurea binding proteins
EP1526383A3 (en) * 1998-08-31 2005-11-16 Pfizer Products Inc. Diarylsulfonylurea binding proteins
AU766809B2 (en) * 1998-10-28 2003-10-23 Rigel Pharmaceuticals, Inc. Novel compositions and methods of screening for T-cell and B-cell activation modulators
US6709855B1 (en) 1998-12-18 2004-03-23 Scios, Inc. Methods for detection and use of differentially expressed genes in disease states
WO2000035473A2 (en) * 1998-12-18 2000-06-22 Scios Inc. Methods for detection and use of differentially expressed genes in disease states
WO2000046370A1 (en) * 1999-02-04 2000-08-10 Board Of Trustees Of The University Of Illinois P37ing1 compositions and methods of use
US6544946B1 (en) 1999-02-19 2003-04-08 Zymogenetics, Inc. Inhibitors for use in hemostasis and immune function
BR0008298A (en) 1999-02-19 2002-02-19 Zymogenetics Inc Methods to promote blood flow within a mammal's vasculature, to pacify damaged collagenous tissues within a mammal, to pacify the surface of a prostatic biomaterial for use in association with a mammal, and to mediate wound repair in a mammal
US6759508B2 (en) 2000-09-01 2004-07-06 Corixa Corporation Compositions and methods for the therapy and diagnosis of lung cancer
US6444425B1 (en) 1999-04-02 2002-09-03 Corixa Corporation Compounds for therapy and diagnosis of lung cancer and methods for their use
KR20020007354A (en) * 1999-04-02 2002-01-26 길리스 스티브 Compounds and methods for therapy and diagnosis of lung cancer
WO2000060077A2 (en) * 1999-04-02 2000-10-12 Corixa Corporation Compounds for therapy and diagnosis of lung cancer and methods for their use
US20030211510A1 (en) 1999-06-30 2003-11-13 Corixa Corporation Compositions and methods for the therapy and diagnosis of lung cancer
US6509448B2 (en) 1999-06-30 2003-01-21 Corixa Corporation Compositions and methods for the therapy and diagnosis of lung cancer
US6914132B1 (en) 1999-06-30 2005-07-05 Corixa Corporation Compositions and methods for the therapy and diagnosis of lung cancer
US6746846B1 (en) 1999-06-30 2004-06-08 Corixa Corporation Methods for diagnosing lung cancer
US6686447B1 (en) 1999-06-30 2004-02-03 Corixa Corporation Compositions and methods for the therapy and diagnosis of lung cancer
US6504010B1 (en) 1999-06-30 2003-01-07 Corixa Corporation Compositions and methods for the therapy and diagnosis of lung cancer
US6858204B2 (en) 1999-06-30 2005-02-22 Corxia Corporation Compositions and methods for the therapy and diagnosis of lung cancer
US20030125245A1 (en) 1999-06-30 2003-07-03 Tongtong Wang Compositions and methods for therapy and diagnosis of lung cancer
US6667154B1 (en) 1999-06-30 2003-12-23 Corixa Corporation Compositions and methods for the therapy and diagnosis of lung cancer
CZ20014718A3 (en) 1999-06-30 2003-01-15 Corixa Corporation Compounds and methods for therapy and diagnostic of lung cancer
CA2309313A1 (en) * 1999-08-05 2001-02-05 Board Of Trustees Of The University Of Arkansas Stimulation of the immune response by human dendritic cell manipulation
WO2001021653A2 (en) * 1999-09-23 2001-03-29 Corixa Corporation Ovarian tumor antigen and methods of use therefor
EP1672070A3 (en) * 1999-12-01 2006-10-04 Genentech, Inc. Secreted and transmembrane polypeptides and nucleic acids encoding the same
AU2001253388A1 (en) * 2000-04-14 2001-10-30 Incyte Genomics, Inc. Molecules associated with human reproduction
EP1366157A2 (en) * 2000-06-29 2003-12-03 Corixa Corporation Compositions and methods for the therapy and diagnosis of lung cancer
CA2415544A1 (en) * 2000-07-11 2002-01-17 Corixa Corporation Compositions and methods for the therapy and diagnosis of lung cancer
AU2001270638A1 (en) * 2000-07-19 2002-01-30 Bayer Aktiengesellschaft Regulation of human airway trypsin protease-like enzyme
DE60130782T2 (en) * 2000-08-28 2008-07-03 Teijin Ltd. AIRWAY-SPECIFIC, TRYPSIN-SIMILAR ENZYMES AND METHODS FOR THEIR APPLICATION
WO2002055694A2 (en) 2001-01-16 2002-07-18 Genset Sa Discriminative nucleic acid analysis using clone sequence signatures
GB0101300D0 (en) * 2001-01-18 2001-02-28 Univ Cambridge Tech Primordial germ cell genes
US7226994B2 (en) 2001-01-18 2007-06-05 Cambridge University Technical Services Limited Cell surface expressed marker of pluripotency
US20050085627A1 (en) 2001-06-21 2005-04-21 Youming Zhang Atopy
US20040081653A1 (en) * 2002-08-16 2004-04-29 Raitano Arthur B. Nucleic acids and corresponding proteins entitled 251P5G2 useful in treatment and detection of cancer
AU2007216892B2 (en) * 2002-08-16 2011-02-10 Agensys, Inc. Nucleic acids and corresponding proteins entitled 273P4B7 useful in treatment and detection of cancer
EP1583548A4 (en) * 2002-12-10 2007-10-17 Epimmune Inc Hla-a1, a2 -a3,-a24,-b7,and -b44 tumor associated antigen peptides and compositions
US20060252057A1 (en) * 2004-11-30 2006-11-09 Mitch Raponi Lung cancer prognostics
ES2531142T3 (en) 2005-10-17 2015-03-11 Sloan Kettering Inst Cancer Class II HLA binding WT1 peptides, and compositions and methods comprising them
EP3117836A1 (en) 2006-04-10 2017-01-18 Sloan Kettering Institute For Cancer Research Immunogenic wt-1 peptides and uses thereof
EP2423332A1 (en) * 2006-08-25 2012-02-29 Oncotherapy Science, Inc. Prognostic markers and therapeutic targets for lung cancer
US20110236314A1 (en) * 2008-09-12 2011-09-29 Cancer Research Initiatives Foundation Method of detection and diagnosis of oral and nasopharyngeal cancers
CN101891802B (en) * 2009-08-11 2011-11-16 武汉凯泰新生物技术有限公司 Polypeptide or derivative product for treating or preventing cancer and application thereof
CN101921313B (en) * 2010-04-07 2012-02-29 武汉凯泰新生物技术有限公司 Polypeptide for curing or preventing cancer or derivative product and application thereof
GB201104286D0 (en) * 2011-03-15 2011-04-27 Randox Lab Ltd Glutathione S-transferase omega 1 wild type specific antibody
US9644026B2 (en) * 2011-09-09 2017-05-09 Trans Genic Inc. Antibody against mutant α-actinin-4
EP3520810A3 (en) 2012-01-13 2019-11-06 Memorial Sloan-Kettering Cancer Center Immunogenic wt1 peptides and use thereof
US10815273B2 (en) 2013-01-15 2020-10-27 Memorial Sloan Kettering Cancer Center Immunogenic WT-1 peptides and methods of use thereof
LT2945647T (en) 2013-01-15 2021-02-25 Memorial Sloan Kettering Cancer Center Immunogenic wt-1 peptides and methods of use thereof
CN109476721B (en) * 2016-04-04 2022-06-28 英蒂分子公司 CD 8-specific capture agents, compositions and methods of use and preparation
CN110139927B (en) * 2016-11-16 2024-06-07 加利福尼亚大学董事会 CRISPR-CAS9 inhibitors
CN110669104B (en) * 2019-10-30 2021-11-05 上海交通大学 Group of markers derived from human peripheral blood mononuclear cells and application thereof
CN112500467B (en) * 2020-12-14 2022-05-24 上海交通大学 Bioactive peptide RRECPSDECGAGVF, and preparation method and application thereof

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5589579A (en) * 1994-07-19 1996-12-31 Cytoclonal Pharmaceutics, Inc. Gene sequence and probe for a marker of non-small cell lung carinoma
US5633161A (en) * 1995-03-29 1997-05-27 Millennium Pharmaceuticals, Inc. Murine gene fomy030 coding for tumor progression inhibitor

Also Published As

Publication number Publication date
EP1051489A2 (en) 2000-11-15
WO1999038973A3 (en) 1999-12-09
NO20003853D0 (en) 2000-07-27
BR9907259A (en) 2002-01-22
IL137417A0 (en) 2001-07-24
ID27813A (en) 2001-04-26
KR20010034436A (en) 2001-04-25
CN1292029A (en) 2001-04-18
JP2002516659A (en) 2002-06-11
CA2319117A1 (en) 1999-08-05
AU2344399A (en) 1999-08-16
WO1999038973A2 (en) 1999-08-05
AR014514A1 (en) 2001-02-28
ZA99693B (en) 1999-10-21

Similar Documents

Publication Publication Date Title
NO20003853L (en) Compounds for therapy and diagnosis of lung cancer and methods for their use
NO20016427D0 (en) Compositions and Methods for the Treatment of Diagnosis of Lung Cancer
NO20010196D0 (en) Compositions and Methods for Therapy and Diagnosis of Prostate Cancer
HUP0200760A2 (en) Compounds and methods for therapy and diagnosis of lung cancer
HK1045332A1 (en) Compounds for therapy and diagnosis of lung cancer and methods for their use
NO20024972D0 (en) Mixtures and Methods for Therapy and Diagnosis of Breast Cancer
NO20023402D0 (en) Mixtures and Methods for the Treatment and Diagnosis of Prostate Cancer
NO20030714D0 (en) Mixtures and Methods for the Treatment and Diagnosis of HER-2 / NEU-Associated Malignancies
PL366626A1 (en) Compositions and methods for the therapy and diagnosis of lung cancer
NO20013002D0 (en) Mixtures and methods for the treatment and diagnosis of ovarian cancer
NO983183L (en) Mixtures and Procedures for the Treatment and Diagnosis of Breast Cancer
NO20010882D0 (en) Therapies for the treatment of lung diseases
NO20014769D0 (en) Preparation for the treatment and diagnosis of breast cancer and methods for its use
NO995690D0 (en) Compounds for the diagnosis of tuberculosis and methods for their use
NO986089D0 (en) Methods and preparations for the treatment of tumors, tumor-related diseases and o
AU2002218770A1 (en) Compositions and methods for the therapy and diagnosis of lung cancer
NO994932D0 (en) Mixtures and Procedures for the Treatment and Diagnosis of Breast Cancer
EP1129217A4 (en) Compositions and methods of disease diagnosis and therapy
NO20014804D0 (en) Compounds for immunotherapy and diagnosis of breast cancer and methods for their use
AU2002359330A1 (en) Compositions and methods for the therapy and diagnosis of lung cancer
NO20025594L (en) Mixtures and Methods for Therapy and Diagnosis of Breast Cancer
AU2001259062A1 (en) Compositions and methods for the therapy and diagnosis of lung cancer
EP1532162A4 (en) Humanized anti-tag-72 cc49 for diagnosis and therapy of human tumors
AU2001273149A1 (en) Compositions and methods for the therapy and diagnosis of lung cancer
AU2003230849A8 (en) Compositions and methods for the therapy and diagnosis of lung cancer